Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.00
-4.09-44.99%
Pre-Market: 6:22 AM EDT
Comments
Loading...
Aardvark Therapeutics Analyst Ratings and Price Targets | NASDAQ:AARD | Benzinga
Aardvark Therapeutics Inc has a consensus price target of $30.5 based on the ratings of 4 analysts. The high is $50 issued by Cantor Fitzgerald on March 10, 2025. The low is $21 issued by RBC Capital on March 10, 2025. The 3 most-recent analyst ratings were released by RBC Capital, Cantor Fitzgerald, and Morgan Stanley on March 10, 2025, respectively. With an average price target of $33.33 between RBC Capital, Cantor Fitzgerald, and Morgan Stanley, there's an implied 566.67% upside for Aardvark Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Cantor Fitzgerald
Morgan Stanley
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Aardvark Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | Buy Now | 320% | RBC Capital | Brian Abrahams52% | → $21 | Initiates | → Outperform | Get Alert |
| 03/10/2025 | Buy Now | 900% | Cantor Fitzgerald | Josh Schimmer55% | → $50 | Initiates | → Overweight | Get Alert |
| 03/10/2025 | Buy Now | 480% | Morgan Stanley | Michael Ulz57% | → $29 | Initiates | → Overweight | Get Alert |
| 03/10/2025 | Buy Now | 340% | B of A Securities | Tim Anderson53% | → $22 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Aardvark Therapeutics (AARD) stock?
The latest price target for Aardvark Therapeutics (NASDAQ:AARD) was reported by RBC Capital on March 10, 2025. The analyst firm set a price target for $21.00 expecting AARD to rise to within 12 months (a possible 320.00% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aardvark Therapeutics (AARD)?
The latest analyst rating for Aardvark Therapeutics (NASDAQ:AARD) was provided by RBC Capital, and Aardvark Therapeutics initiated their outperform rating.
When was the last upgrade for Aardvark Therapeutics (AARD)?
There is no last upgrade for Aardvark Therapeutics
When was the last downgrade for Aardvark Therapeutics (AARD)?
There is no last downgrade for Aardvark Therapeutics.
When is the next analyst rating going to be posted or updated for Aardvark Therapeutics (AARD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aardvark Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aardvark Therapeutics was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
Is the Analyst Rating Aardvark Therapeutics (AARD) correct?
While ratings are subjective and will change, the latest Aardvark Therapeutics (AARD) rating was a initiated with a price target of $0.00 to $21.00. The current price Aardvark Therapeutics (AARD) is trading at is $5.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.